Articles

Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas

University of Chicago, Chicago, IL
University of Chicago, Chicago, IL
University of Chicago, Chicago, IL
Illinois Cancer Care, Peoria, IL
University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA; Amgen Inc., Thousand Oaks, CA
Northwestern University, Chicago, IL, USA; Daiichi-Sankyo, Basking Ridge, NJ
Fort Wayne Oncology/Hematology, Fort Wayne, IN
Southern Illinois University, Springfield, IL
Mercy Hospital, St. Louis, IL
University of Chicago, Chicago, IL
Weill Cornell Medicine, New York, NY
University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
University of Chicago, Chicago, IL
Haematologica Early view Jul 29, 2021 https://doi.org/10.3324/haematol.2021.278853